Prm18 - Real-World Data (Rwd) Collection Alongside Early Access to Medicines Schemes (Eams) - Nivolumab in Gastric or Gastroesophageal Junction Adenocarcinoma (Gc/Gej) After Two or More Prior Therapies
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2142